MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST000475/mwtabprimaryOK200Mass SpectrometryESICancerhttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST000475Treatment:MDH inhibTreatment:-Leukemia CellsUHPLC POSITIVE ION MODE. UHPLC NEGATIVE ION MODE.MetabolomicsWorkbenchMetabolomicsHomo SapiensUniversity of FloridaSARCOSINE/BETA-ALANINEPEG n5BETAINEL-Leucine-D10THREONINE/HOMOSERINEFructose 1,6-bisphosphateINOSINECITRATE4-AMINOBUTANOATE (GABA)METHYL BETA-D-GALACTOSIDETrigonellineCYS-GLYL-Tryptophan-13C11Pyroglutamic AcidMALATECMPL-METHIONINEL-GLUTAMINEGLUCOSAMINE/MANNOSAMINEHEXOSE-6-PHOSPHATEGLUTATHIONEURIDINE-5-MONOPHOSPHATEHEXOSE-DISACCHARIDEGlycerophosphocholineGLUCOSE/FRUCTOSE_R2GLUCOSE/FRUCTOSE_R1LL-2,6-DIAMINOHEPTANEDIOATEOrthophosphatePHOSPHOCHOLINETryptophan-NH3ButyrylcarnitinePantothenic Acid1-AMINOCYCLOPROPANE-1-CARBOXYLATETRANS-CINNAMATED-RIBOSE 5-PHOSPHATE/RIBULOSE 5-PHOSPHATEISOCITRIC ACIDC12H22O11-DISACCHARIDE-(6C/6C; GLC-GLC/GLC-FRC/GAL-GLC)GLYCEROL 2-PHOSPHATE/SN-GLYCEROL 3-PHOSPHATELeu Pro3-tert-Butyladipic acidADENINEN-ACETYL-DL-GLUTAMIC ACIDCITRIC ACID-13C6LysoPE (18:1)URATETryptophanPHENETHYLAMINEC6H12O6-HEXOSE/KETOSE/INOSITOLGUANOSINEN-ACETYLNEURAMINATETryptophan-2,3,3-D3L-CARNITINEHYPOXANTHINECholineL-Tryptophan 13C11N-ACETYL-L-ASPARTIC ACIDCREATININEL-Tyrosine 13C6DIETHANOLAMINEALDOPENTOSELEUCINETriethyl phosphateDibutyl phthalateGLYCERALDEHYDE/LACTATEL-Phenylalanine 13C6DiphenylamineADPL-IsoleucineLysoPE (20:4)CREATINEDIHYDROXYACETONE PHOSPHATETryptophan-2,3,3-D3-NH34-oxoprolineL-VALINE/5-AMINOPENTANOATE/L-NORVALINEL-CYSTEINEDipropylene glycolL-Leucine 13C6ErucamideN-BOC-L-Aspartic AcidGlycyl-L-leucineCYTOSINE4-HYDROXYPROLINEDISACCHARIDE (6C/6C)/2-alpha-D-glucosyl-D-glucose3-UREIDOPROPIONATECreatine-D3Monobutyl phthalateLysoPE (18:0)L-PROLINEASPARTATEALDO/KETO-HEXOSEALANINE/SARCOSINEGUANINEMono-(2-Ethylhexyl) PhthalateDinoterb (herbicide)L-GLUTAMIC ACIDIsocytosineN-ACETYL-HEXOSAMINETAURINELysoPC (18:2)N-ACETYLPUTRESCINEDmelCG7998, inhibitors, L(+)-mandelate dehydrogenase activity, NAD-dependent malate dehydrogenase activity, NAD-L-malate dehydrogenase activity, DmelCG10120, sMdh, quinoprotein alcohol dehydrogenase activity, MDH, quinoprotein ethanol dehydrogenase activity, Mdh, Metabonomic, NAD-malate dehydrogenase activity, inhibitor, Metabonomics, ME, Mdh-1, Mdh-2, L-malate-NAD+ oxidoreductase activity, MDH-1, NAD-malic dehydrogenase activity, MDH-2, CG7998, mMdh, Metabolomic, Me, CT17038, DmelCG5362, antagonists, M-MDH, MGC:3559, PQQ-dependent alcohol dehydrogenase activity, malic acid dehydrogenase activity, NAD-linked malate dehydrogenase activity, (S)-malate:NAD+ oxidoreductase activity, inhibiteur, mem, alcohol:acceptor oxidoreductase activity, men, antagonists and inhibitors., MGC - 3559, quinohemoprotein alcohol dehydrogenase activity, malic dehydrogenase activity, cMdh, primary alcohol dehydrogenase, (S)-2-hydroxy-2-phenylacetate:acceptor 2-oxidoreductase activity, MOR1, Mor-1, Mor1, Mdh2, NAD-specific malate dehydrogenase activity, inhibidor, alcohol:(acceptor) oxidoreductase activity, CG5362, l(3)psg7, anon-WO0118547.278, MdhD, malate (NAD) dehydrogenase activity, NAD-dependent malic dehydrogenase activity, CG 7998, Mdh-NADP, CG10120iones., Ionen, ion, Ion, ions, ionesfalseMetabolomic testing of a putative MDH inhibitor (global)ST0004759606